GlassScriptPhysician profile
Parkson J Lin
NPI 1285683920
$10,965.73
in general payments reported to CMS, 2019-2025
31 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,000 · 2020: $1,274 · 2021: $1,489 · 2022: $1,483 · 2023: $773 · 2024: $1,764 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,314 · Travel and Lodging: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,313.77 |
| Travel and Lodging | $406.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,496.03 | 2019-2023 | Collagenase Santyl, Regranex, Renasys Go V2 Home |
| Stryker Corporation | $2,069.44 | 2019-2025 | Citrefix, Prostep |
| Treace Medical Concepts, INC. | $963.03 | 2019-2025 | |
| Pfizer INC. | $813.84 | 2019-2022 | |
| Amgen INC. | $744.48 | 2024-2025 | Krystexxa |
| Ossio INC | $669.20 | 2022 | |
| Fusion Orthopedics USA, LLC | $518.29 | 2024 | |
| Inari Medical, INC. | $318.93 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Linvatec Corporation | $226.05 | 2025 | Biobrace 23mm, Allograft Tissue, 5ms |
| Paragon 28, INC. | $213.65 | 2019-2022 | |
| Globus Medical, INC. | $171.76 | 2025 | Senza |
| Curonix LLC | $149.94 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $146.26 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Integra Lifesciences Corporation | $142.16 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Koya Medical, INC. | $136.95 | 2024 | Dayspring, Koya Medical |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $135.40 | 2022 | |
| Arthrex, INC. | $134.68 | 2019 | |
| Organogenesis INC. | $123.64 | 2023 | Puraply |
| Boston Scientific Corporation | $118.55 | 2024 | |
| Horizon Therapeutics Plc | $116.66 | 2023 | Krystexxa |
| Averitas Pharma INC. | $100.36 | 2023 | Qutenza |
| Djo, LLC | $90.66 | 2024 | Cmf |
| Crossroads Extremity Systems, LLC | $70.07 | 2019 | |
| Zimmer Biomet Holdings, INC. | $68.09 | 2020 | |
| Bioventus LLC | $53.72 | 2024 | Exogen Ultrasound Bone Healing System |
| Novastep INC. | $50.55 | 2025 | Nexis |
| Tactile Systems Technology INC | $47.98 | 2019-2021 | |
| Alfasigma USA, INC. | $20.14 | 2021 | |
| Advanced Oxygen Therapy INC. | $19.29 | 2022 | |
| Reprise Biomedical, INC. | $17.99 | 2024 | Miro3d |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parkson Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.